REGULATED INFORMATION Description of the regulatory framework of the share repurchase programproposed by the Board of Directors to be approved at theCombined Shareholders’ Meeting. | May 31, 2023
Dr. Søren Mouritsen, co-founder of Engimmune, steps down as Chief Executive Officer in planned transitionBASEL, Switzerland, April 19, 2023 /PRNewswire/ Engimmune Therapeutics AG ("Engimmune")